CD8A and neoplasm: To identify regulators that determine anti-tumor T-cell response, we first reanalyzed a recently published genome-scale CRISPR/Cas9 screen dataset that sought to identify tumor cell-intrinsic modulators of antigen-specific OT-1 and Pmel-1 CD8+ T-cell cytotoxicity  in vitro43.